Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRNX | INDV | NAMS | ||
| Company | Crinetics Pharmaceuticals Inc | Indivior Pharmaceuticals Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.28 | 29.77 | 30.96 | ||
| High | 36.33 | 30.10 | 31.26 | ||
| Low | 33.31 | 28.90 | 29.92 | ||
| Latest | 33.67 | 28.97 | 29.98 | ||
| Change | -2.64 | -0.98 | -1.27 | ||
| % Change | -7.27% | -3.27% | -4.06% | ||
| Volume | 1,461,500 | 1,438,600 | 745,500 | ||
| 20-Day Average Volume | 1,244,300 | 3,843,295 | 931,670 | ||
| Previous Close | 36.31 | 29.95 | 31.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.10 | 31.00 | 30.39 | ||
| 20-Day Raw Stochastic | 4.07% | 16.84% | 22.10% | ||
| 20-Day Relative Strength | 30.95 | 37.12 | 44.68 | ||
| Weighted Alpha | -18.61 | +131.71 | +39.26 | ||
| Today's Opinion | 56% Sell | 24% Sell | 56% Sell | ||
| Previous Opinion | 56% Sell | 24% Sell | 24% Sell | ||
| Last Month's Opinion | 8% Buy | 40% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.34% since 03/20/26 | -1.13% since 03/20/26 | +3.59% since 03/20/26 | ||
| Low | 33.31 on 03/27/26 | 27.68 on 03/24/26 | 28.81 on 03/23/26 | ||
| High | 36.86 on 03/26/26 | 30.79 on 03/26/26 | 32.15 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -18.08% since 02/27/26 | -11.46% since 02/27/26 | -15.45% since 02/27/26 | ||
| Low | 33.31 on 03/27/26 | 27.68 on 03/24/26 | 28.53 on 03/13/26 | ||
| High | 42.03 on 03/02/26 | 35.34 on 03/11/26 | 35.09 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -29.80% since 12/26/25 | -19.99% since 12/26/25 | -15.00% since 12/26/25 | ||
| Low | 33.31 on 03/27/26 | 27.68 on 03/24/26 | 28.53 on 03/13/26 | ||
| High | 57.99 on 01/05/26 | 37.66 on 01/08/26 | 37.76 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -26.66% since 09/26/25 | +21.11% since 09/26/25 | +5.19% since 09/26/25 | ||
| Low | 33.31 on 03/27/26 | 22.56 on 10/06/25 | 27.14 on 09/30/25 | ||
| High | 57.99 on 01/05/26 | 38.00 on 12/08/25 | 42.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,525,417 | 3,623,133 | 3,446,950 | ||
| Shares Outstanding, K | 104,705 | 125,065 | 114,975 | ||
| Annual Sales | 7,700,000 | 1,239,000,000 | 22,500,000 | ||
| Annual Net Income | -465,320,000 | 210,000,000 | -203,820,000 | ||
| Last Quarter Sales | 6,160,000 | 357,000,000 | 30,000 | ||
| Last Quarter Net Income | -122,820,000 | 103,000,000 | -74,920,000 | ||
| 60-Month Beta | 0.23 | 0.83 | 0.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.29 on 02/26/26 | 0.82 on 02/26/26 | -0.63 on 02/18/26 | ||
| Latest Earnings Date | 05/14/26 | 04/23/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.17 | 0.00 | ||